Thrombophilia and pregnancy complications.
Thrombophilic risk factors are common and can be found in 15% to 25% of Caucasian populations. Since pregnancy is an acquired hypercoagulable state, women harboring thrombophilia may present with clinical symptoms of vascular complications for the first time during gestation or at the postpartum period(1). Women with thrombophilia may have an increased risk of placental vascular complications, including pregnancy loss, preeclampsia, intrauterine growth restriction,and placental abruption. Accumulating data suggest that maternal antithrombotic prophylaxis may result in improved gestational outcome. Randomized trials are under way and hopefully will optimize maternal and neonatal outcome.
Brenner
Benjamin
B
Department of Hematology and Bone Marrow Transplantation, Thrombosis and Hemostasis Unit, Rambam Medical Center, BruceRappaport Faculty of Medicine, Haifa, Israel. b_brenner@rambam.health.gov.il
D000328:Adult; D005260:Female; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006487:Hemostasis; D006801:Humans; D011247:Pregnancy; D011248:Pregnancy Complications / Q000209:etiology* / Q000517:prevention & control; D012307:Risk Factors; D019851:Thrombophilia / Q000150:complications* / Q000209:etiology; D013927:Thrombosis / Q000209:etiology / Q000517:prevention & control
D005343:Fibrinolytic Agents